The hypothalamo-GH axis: The past 60 years

Journal of Endocrinology

Volumn 226, Issue 2, 2015, Pages T123-T140

  Murray, P G ^a,b   Higham, C E ^a,c   Clayton, P E ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Growth hormone; History; Hypothalamus; Pituitary

Indexed keywords

ADIPONECTIN; CORTICOTROPIN; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; G PROTEIN COUPLED RECEPTOR; GENOMIC DNA; GHRELIN; GROWTH FACTOR; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HUMAN GROWTH HORMONE; HYPOPHYSIS HORMONE; INSULIN; KISSPEPTIN; LUTEINIZING HORMONE; PROLACTIN; PROTIRELIN; RELEASING FACTOR; SOMATOMEDIN C; SOMATOSTATIN; TESTOSTERONE;

ACROMEGALY; ADRENERGIC STIMULATION; ALTERNATIVE RNA SPLICING; BODY COMPOSITION; CALCIUM CELL LEVEL; CHRONIC KIDNEY FAILURE; CREUTZFELDT JAKOB DISEASE; ESTROGEN THERAPY; GENE MUTATION; GLUCOSE TRANSPORT; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH HORMONE SECRETING ADENOMA; GROWTH RATE; HUMAN; HYPOGLYCEMIA; HYPOPHYSIS FUNCTION; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INSULIN RELEASE; INSULIN TOLERANCE TEST; LOSS OF FUNCTION MUTATION; META ANALYSIS (TOPIC); NONHUMAN; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; SKULL IRRADIATION; SMALL FOR DATE INFANT; TRANSSPHENOIDAL HYPOPHYSECTOMY; TURNER SYNDROME; ANIMAL; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM;

ANIMALS; GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY GLAND;

EID: 84942582019     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-15-0120     Document Type: Review

References (136)

1. Abu Dabrh AM, Mohammed K, Asi N, Farah WH, Wang Z, Farah MH, Prokop LJ, Katznelson L&Murad MH 2014 Surgical interventions and medical treatments in treatment-naive patients with acromegaly: systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 99 4003-4014. (doi:10.1210/jc.2014-2900)
2. Ahmed SR, Shalet SM&Beardwell CG 1986 The effects of cranial irradiation on growth hormone secretion. Acta Paediatrica Scandinavica 75 255-260. (doi:10.1111/j.1651-2227.1986.tb10195.x)
3. Alatzoglou KS&Dattani MT 2010 Genetic causes and treatment of isolated growth hormone deficiency - an update. Nature Reviews. Endocrinology 6 562-576. (doi:10.1038/nrendo.2010.147)
4. Alatzoglou KS, Webb EA, Le Tissier P&Dattani MT 2014 Isolated growth hormone deficiency (GHD) in childhood and adolescence: recent advances. Endocrine Reviews 35 376-432. (doi:10.1210/er.2013-1067)
5. Avtanski D, Novaira HJ, Wu S, Romero CJ, Kineman R, Luque RM, Wondisford F&Radovick S 2014 Both estrogen receptor a and b stimulate pituitary GH gene expression. Molecular Endocrinology 28 40-52. (doi:10.1210/me.2013-1245)
6. Baragli A, Lanfranco F, Allasia S, Granata R& Ghigo E 2011 Neuroendocrine and metabolic activities of ghrelin gene products. Peptides 32 2323-2332. (doi:10.1016/j.peptides.2011.10.024)
7. Bartke A&Brown-Borg H 2004 Life extension in the dwarf mouse. Current Topics in Developmental Biology 63 189-225. (doi:10.1016/S0070-2153(04)63006-7)
8. Beck C, Larkins RG, Martin TJ&Burger HG 1973 Stimulation of growth hormone release from superfused rat pituitary by extracts of hypothalamus and of human lung tumours. Journal of Endocrinology 59 325-333. (doi:10.1677/joe.0.0590325)
9. Berryman DE, List EO, Coschigano KT, Behar K, Kim JK&Kopchick JJ 2004 Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Hormone&IGF Research 14 309-318. (doi:10.1016/j.ghir.2004.02.005)
10. Berryman DE, List EO, Sackmann-Sala L, Lubbers E, Munn R&Kopchick JJ 2011 Growth hormone and adipose tissue: beyond the adipocyte. Growth Hormone&IGF Research 21 113-123. (doi:10.1016/j.ghir.2011.03.002)
11. Berryman DE, Glad CA, List EO&Johannsson G 2013 The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nature Reviews. Endocrinology 9 346-356. (doi:10.1038/nrendo.2013.64)
12. Besson A, Salemi S, Gallati S, Jenal A, Horn R, Mullis PS&Mullis PE 2003 Reduced longevity in untreated patients with isolated growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 88 3664-3667. (doi:10.1210/jc.2002-021938)
13. Blatt J, Bercu BB, Gillin JC, Mendelson WB&Poplack DG 1984 Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. Journal of Pediatrics 104 182-186. (doi:10.1016/S0022-3476(84)80989-0)
14. Blizzard RM 2012 History of growth hormone therapy. Indian Journal of Pediatrics 79 87-91. (doi:10.1007/s12098-011-0609-4)
15. Boehm BO 2007 Use of long-acting somatostatin analogue treatment in diabetic retinopathy. Developments in Ophthalmology 39 111-121. (doi:10.1159/000098503)
16. Bohlen P, Brazeau P, Bloch B, Ling N, Gaillard R&Guillemin R 1983 Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. Biochemical and Biophysical Research Communications 114 930-936. (doi:10.1016/0006-291X(83)90649-6)
17. Bowers CY, Chang JK, Wong TTW 1977 A synthetic pentapeptide which specifically releases GH in vitro. In 59th Annual Meeting of the Endocrine Society, Chicago, IL, USA. p 232.
18. Bowers CY, Momany F, Reynolds GA, Chang D, Hong A&Chang K 1980 Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology 106 663-667. (doi:10.1210/endo-106-3-663)
19. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS&Thorner MO 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. Journal of Clinical Endocrinology and Metabolism 70 975-982. (doi:10.1210/jcem-70-4-975)
20. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J&Guillemin R 1973 Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179 77-79. (doi:10.1126/science.179.4068.77)
21. Brown-Borg HM, Borg KE, Meliska CJ&Bartke A 1996 Dwarf mice and the ageing process. Nature 384 33. (doi:10.1038/384033a0)
22. Cai Y, Xu M, Yuan M, Liu Z&Yuan W 2014 Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes. International Journal of Nanomedicine 9 3527-3538. (doi:10.2147/IJN.S63507)
23. Camanni F, Ghigo E&Arvat E 1998 Growth hormone-releasing peptides and their analogs. Frontiers in Neuroendocrinology 19 47-72. (doi:10.1006/frne.1997.0158)
24. Camina JP, Carreira MC, Micic D, Pombo M, Kelestimur F, Dieguez C & Casanueva FF 2003 Regulation of ghrelin secretion and action. Endocrine 22 5-12. (doi:10.1385/ENDO:22:1:5)
25. Carro E, Senaris R, Considine RV, Casanueva FF&Dieguez C 1997 Regulation of in vivo growth hormone secretion by leptin. Endocrinology 138 2203-2206. (doi:10.1210/endo.138.5.5238)
26. Chen WY, White ME, Wagner TE&Kopchick JJ 1991 Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. Endocrinology 129 1402-1408. (doi:10.1210/endo-129-3-1402)
27. Chrousos GP, Poplack D, Brown T, O'Neill D, Schwade J&Bercu BB 1982 Effects of cranial radiation on hypothalamic-adenohypophyseal function: abnormal growth hormone secretory dynamics. Journal of Clinical Endocrinology and Metabolism 54 1135-1139. (doi:10.1210/jcem-54-6-1135)
28. Clayton PE, Gill MS, Tillmann V&Westwood M 2014 Translational neuroendocrinology: control of human growth. Journal of Neuroendocrinology 26 349-355. (doi:10.1111/jne.12156)
29. Cogan JD, Phillips JA III, Schenkman SS, Milner RD&Sakati N 1994 Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric protein. Journal of Clinical Endocrinology and Metabolism 79 1261-1265. (doi:10.1210/jcem.79.5.7962317)
30. Cordido F, Peino R, Penalva A, Alvarez CV, Casanueva FF&Dieguez C 1996 Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression. Journal of Clinical Endocrinology and Metabolism 81 914-918. (doi:10.1210/jcem.81.3.8772550)
31. Cornford AS, Barkan AL&Horowitz JF 2011 Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 96 824-830. (doi:10.1210/jc.2010-1895)
32. Cornford AS, Barkan AL, Hinko A&Horowitz JF 2012 Suppression in growth hormone during overeating ameliorates the increase in insulin resistance and cardiovascular disease risk. American Journal of Physiology. Endocrinology and Metabolism 303 E1264-E1272. (doi:10.1152/ajpendo.00320.2012)
33. Coschigano KT, Clemmons D, Bellush LL&Kopchick JJ 2000 Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141 2608-2613. (doi:10.1210/endo.141.7.7586)
34. CroninMJ 1997 Pioneering recombinant growth hormone manufacturing: pounds produced per mile of height. Journal of Pediatrics 131 S5-S7. (doi:10.1016/S0022-3476(97)70002-7)
35. Darzy KH, Pezzoli SS, Thorner MO&Shalet SM 2007 Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal. Journal of Clinical Endocrinology and Metabolism 92 1666-1672. (doi:10.1210/jc.2006-2599)
36. Deuben RR&Meites J 1964 Stimulation of pituitary growth hormone release by a hypothalamic extract in vitro. Endocrinology 74 408-414. (doi:10.1210/endo-74-3-408)
37. Evans HM&Long JA 1921 The effect of the anterior lobe administered intraperitoneally upon growth maturation, and oestrus cycles of the rat. Anatomical Record 21 62-63.
38. Flurkey K, Papaconstantinou J, Miller RA&Harrison DE 2001 Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. PNAS 98 6736-6741. (doi:10.1073/pnas.111158898)
39. Frantz AG&Rabkin MT 1965 Effects of estrogen and sex difference on secretion of human growth hormone. Journal of Clinical Endocrinology and Metabolism 25 1470-1480. (doi:10.1210/jcem-25-11-1470)
40. Gadelha MR, Bronstein MD, Brue T, Coculescu M, Fleseriu M, Guitelman M, Pronin V, Raverot G, Shimon I, Lievre KK et al. 2014 Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial. Lancet. Diabetes&Endocrinology 2 875-884. (doi:10.1016/S2213-8587(14)70169-X)
41. Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E&Camanni F 1996 New approach to the diagnosis of growth hormone deficiency in adults. European Journal of Endocrinology 134 352-356. (doi:10.1530/eje.0.1340352)
42. Gill MS, Tillmann V, Veldhuis JD&Clayton PE 2001 Patterns of GH output and their synchrony with short-term height increments influence stature and growth performance in normal children. Journal of Clinical Endocrinology and Metabolism 86 5860-5863. (doi:10.1210/jcem.86.12.8116)
43. Giustina A&Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews 19 717-797. (doi:10.1210/edrv.19.6.0353)
44. Glick SM, Roth J, Yalow RS&Berson SA 1963 Immunoassay of human growth hormone in plasma. Nature 199 784-787. (doi:10.1038/199784a0)
45. Goodman RH, Jacobs JW, Chin WW, Lund PK, Dee PC&Habener JF 1980 Nucleotide sequence of a cloned structural gene coding for a precursor of pancreatic somatostatin. PNAS 77 5869-5873. (doi:10.1073/pnas.77.10.5869)
46. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, Hwang D, Martin-Montalvo A, Saavedra J, Ingles S et al.2011 Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Science Translational Medicine 3 70ra13. (doi:10.1126/scitranslmed.3001845)
47. Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N & Wehrenberg WB 1982 Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218 585-587. (doi:10.1126/science.6812220)
48. Hartmann BW, Kirchengast S, Albrecht A, Huber JC&Soregi G 1997 Effect of hormone replacement therapy on growth hormone stimulation in women with premature ovarian failure. Fertility and Sterility 68 103-107. (doi:10.1016/S0015-0282(97)81483-5)
49. Higham CE&Trainer PJ 2008 Growth hormone excess and the development of growth hormone receptor antagonists. Experimental Physiology 93 1157-1169. (doi:10.1113/expphysiol.2008.042515)
50. Hindmarsh PC, Fall CH, Pringle PJ, Osmond C&Brook CG 1997 Peak and trough growth hormone concentrations have different associations with the insulin-like growth factor axis, body composition, and metabolic parameters. Journal of Clinical Endocrinology and Metabolism 82 2172-2176. (doi:10.1210/jcem.82.7.4036)
51. Houssay BA 1936 The hypophysis and metabolism. New England Journal of Medicine 214 961-985. (doi:10.1056/NEJM193605142142001)
52. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J et al. 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 974-977. (doi:10.1126/science.273.5277.974)
53. Hudson SB, Schroeder DR, Bailey JN, Mielke KL, Erickson D, Miles JM, Bowers CY&Veldhuis JD 2010 Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp. Journal of Clinical Endocrinology and Metabolism 95 353-360. (doi:10.1210/jc.2009-1769)
54. Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA&Morris HR 1975 Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258 577-580. (doi:10.1038/258577a0)
55. Ingraham HA, Chen RP, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons DM, Swanson L&Rosenfeld MG 1988 A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55 519-529. (doi:10.1016/0092-8674(88)90038-4)
56. Iranmanesh A, Lizarralde G&Veldhuis JD 1991 Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism 73 1081-1088. (doi:10.1210/jcem-73-5-1081)
57. Jalalipour M, Najafabadi AR, Gilani K, Esmaily H&Tajerzadeh H 2008 Effect of dimethyl-b-cyclodextrin concentrations on the pulmonary delivery of recombinant human growth hormone dry powder in rats. Journal of Pharmaceutical Sciences 97 5176-5185. (doi:10.1002/jps.21353)
58. Jayasena CN, Comninos AN, Narayanaswamy S, Bhalla S, Abbara A, Ganiyu-Dada Z, Busbridge M, Ghatei MA, Bloom SR&Dhillo WS 2014 Acute and chronic effects of kisspeptin-54 administration on GH, prolactin and TSH secretion in healthy women. Clinical Endocrinology 81 891-898. (doi:10.1111/cen.12512)
59. Karpe F, Dickmann JR&Frayn KN 2011 Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60 2441-2449. (doi:10.2337/db11-0425)
60. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC&Dattani MT 2009 Genetic regulation of pituitary gland development in human and mouse. Endocrine Reviews 30 790-829. (doi:10.1210/er.2009-0008)
61. Kemp SF, Fielder PJ, Attie KM, Blethen SL, Reiter EO, Ford KM, Marian M, Dao LN, Lee HJ&Saenger P 2004 Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children. Journal of Clinical Endocrinology and Metabolism 89 3234-3240. (doi:10.1210/jc.2003-030825)
62. Kerrigan JR&Rogol AD 1992 The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence. Endocrine Reviews 13 281-298. (doi:10.1210/edrv-13-2-281)
63. Khadilkar V, Radjuk KA, Bolshova E, Khadgawat R, El Kholy M, Desai M, Peterkova V, Mericq V, Kratzsch J, Siepl EC et al. 2014 24-Month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency. Journal of Clinical Endocrinology and Metabolism 99 126-132. (doi:10.1210/jc.2013-2502)
64. Khatib MN, Simkhada P&Gode D 2014 Cardioprotective effects of ghrelin in heart failure: from gut to heart. Heart Views 15 74-76. (doi:10.4103/1995-705X.144792)
65. Koch TK, Berg BO, De Armond SJ&Gravina RF 1985 Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. New England Journal of Medicine 313 731-733. (doi:10.1056/NEJM198509193131206)
66. Koerker DJ, Ruch W, Chideckel E, Palmer J, Goodner CJ, Ensinck J & Gale CC 1974 Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 184 482-484. (doi:10.1126/science.184.4135.482)
67. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H&Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 656-660. (doi:10.1038/45230)
68. Kopchick JJ, Parkinson C, Stevens EC&Trainer PJ 2002 Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocrine Reviews 23 623-646. (doi:10.1210/er.2001-0022)
69. Lam KS, Xu A, Tan KC, Wong LC, Tiu SC&Tam S 2004 Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. Journal of Clinical Endocrinology and Metabolism 89 5448-5453. (doi:10.1210/jc.2003-032023)
70. Lee MS, Wajnrajch MP, Kim SS, Plotnick LP, Wang J, Gertner JM, Leibel RL & Dannies PS 2000 Autosomal dominant growth hormone (GH) deficiency type II: the Del32-71-GH deletion mutant suppresses secretion of wild-type GH. Endocrinology 141 883-890. (doi:10.1210/endo.141.3.7380)
71. van der Lely AJ, Tschop M, Heiman ML&Ghigo E 2004 Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocrine Reviews 25 426-457. (doi:10.1210/er.2002-0029)
72. Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH, Leong GM, Ross RJ&Ho KK 2003 Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. PNAS 100 1016-1021. (doi:10.1073/pnas.0337600100)
73. Li S, Crenshaw EB III, Rawson EJ, Simmons DM, Swanson LW & Rosenfeld MG 1990 Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347 528-533. (doi:10.1038/347528a0)
74. Lin SC, Lin CR, Gukovsky I, Lusis AJ, Sawchenko PE&Rosenfeld MG 1993 Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 364 208-213. (doi:10.1038/364208a0)
75. Ling N, Esch F, Bohlen P, Brazeau P, Wehrenberg WB&Guillemin R 1984 Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. PNAS 81 4302-4306. (doi:10.1073/pnas.81.14.4302)
76. Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM&Hoffman AR 2007 Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Annals of Internal Medicine 146 104-115. (doi:10.7326/0003-4819-146-2-200701160-00005)
77. Luque RM, Gahete MD, Valentine RJ&Kineman RD 2006 Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis. Journal of Molecular Endocrinology 37 25-38. (doi:10.1677/jme.1.02042)
78. Madsen M, Poulsen PL, Orskov H, Moller N&Jorgensen JO 2011 Cotreatment with pegvisomant and a somatostatin analog (SA) in SA-responsive acromegalic patients. Journal of Clinical Endocrinology and Metabolism 96 2405-2413. (doi:10.1210/jc.2011-0654)
79. Makimura H, Stanley T, Mun D, You SM&Grinspoon S 2008 The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. Journal of Clinical Endocrinology and Metabolism 93 4254-4260. (doi:10.1210/jc.2008-1333)
80. Mayo KE 1992 Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Molecular Endocrinology 6 1734-1744. (doi:10.1210/mend.6.10.1333056)
81. Mayo KE, Vale W, Rivier J, Rosenfeld MG&Evans RM 1983 Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor. Nature 306 86-88. (doi:10.1038/306086a0)
82. Mayo KE, Cerelli GM, Lebo RV, Bruce BD, Rosenfeld MG&Evans RM 1985 Gene encoding human growth hormone-releasing factor precursor: structure, sequence, and chromosomal assignment. PNAS 82 63-67. (doi:10.1073/pnas.82.1.63)
83. McGuinness L, Magoulas C, Sesay AK, Mathers K, Carmignac D, Manneville JB, Christian H, Phillips JA III&Robinson IC 2003 Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice. Endocrinology 144 720-731. (doi:10.1210/en.2002-220847)
84. Meinhardt UJ&Ho KK 2006 Modulation of growth hormone action by sex steroids. Clinical Endocrinology 65 413-422. (doi:10.1111/j.1365-2265.2006.02676.x)
85. Muller E&Pecile A 1965 Growth hormone releasing factor of a guinea-pig hypothalamic extract: its activity in guinea pig and rat. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 119 1191-1194. (doi:10.3181/00379727-119-30411)
86. Muller E, Pecile A&Smirne S 1965 Substances present at the hypothalamic level and growth hormone releasing activity. Endocrinology 77 390-392. (doi:10.1210/endo-77-2-390)
87. Murray RD&Melmed S 2008 A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly. Journal of Clinical Endocrinology and Metabolism 93 2957-2968. (doi:10.1210/jc.2008-0027)
88. Nass R 2013 Growth hormone axis and aging. Endocrinology and Metabolism Clinics of North America 42 187-199. (doi:10.1016/j.ecl.2013.02.001)
89. Netchine I, Sobrier ML, Krude H, Schnabel D, Maghnie M, Marcos E, Duriez B, Cacheux V, Moers A, Goossens M et al. 2000 Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nature Genetics 25 182-186. (doi:10.1038/76041)
90. Nilsson L, Binart N, Bohlooly YM, Bramnert M, Egecioglu E, Kindblom J, Kelly PA, Kopchick JJ, Ormandy CJ, Ling C et al. 2005 Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochemical and Biophysical Research Communications 331 1120-1126. (doi:10.1016/j.bbrc.2005.04.026)
91. Norman C, Rollene N, Weist SM, Wigham JR, Erickson D, Miles JM, Bowers CY&Veldhuis JD 2014 Short-term estradiol supplementation potentiates low-dose ghrelin action in the presence of GHRH or somatostatin in older women. Journal of Clinical Endocrinology and Metabolism 99 E73-E80. (doi:10.1210/jc.2013-3043)
92. Ohta K, Nobukuni Y, Mitsubuchi H, Fujimoto S, Matsuo N, Inagaki H, Endo F&Matsuda I 1992 Mutations in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochemical and Biophysical Research Communications 189 851-855. (doi:10.1016/0006-291X(92)92281-2)
93. Orme SM, McNally RJ, Cartwright RA&Belchetz PE 1998 Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism 83 2730-2734. (doi:10.1210/jcem.83.8.5007)
94. Ozata M, Dieguez C&Casanueva FF 2003 The inhibition of growth hormone secretion presented in obesity is not mediated by the high leptin levels: a study in human leptin deficiency patients. Journal of Clinical Endocrinology and Metabolism 88 312-316. (doi:10.1210/jc.2002-020122)
95. Patel YC, Greenwood MT, Panetta R, Demchyshyn L, Niznik H&Srikant CB 1995 The somatostatin receptor family. Life Sciences 57 1249-1265. (doi:10.1016/0024-3205(95)02082-T)
96. Pfaffle RW, DiMattia GE, Parks JS, Brown MR, Wit JM, Jansen M, Van der Nat H, Van den Brande JL, Rosenfeld MG&Ingraham HA 1992 Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 257 1118-1121. (doi:10.1126/science.257.5073.1118)
97. Pijl H, Langendonk JG, Burggraaf J, Frolich M, Cohen AF, Veldhuis JD & Meinders AE 2001 Altered neuroregulation of GH secretion in viscerally obese premenopausal women. Journal of Clinical Endocrinology and Metabolism 86 5509-5515. (doi:10.1210/jcem.86.11.8061)
98. Pincus SM, Veldhuis JD&Rogol AD 2000 Longitudinal changes in growth hormone secretory process irregularity assessed transpubertally in healthy boys. American Journal of Physiology. Endocrinology and Metabolism 279 E417-E424.
99. Plotnick LP, Thompson RG, Kowarski A, de Lacerda L, Migeon CJ & Blizzard RM 1975 Circadian variation of integrated concentration of growth hormone in children and adults. Journal of Clinical Endocrinology and Metabolism 40 240-247. (doi:10.1210/jcem-40-2-240)
100. Pong SS, Chaung LY, Dean DC, Nargund RP, Patchett AA&Smith RG 1996 Identification of a new G-protein-linked receptor for growth hormone secretagogues. Molecular Endocrinology 10 57-61. (doi:10.1210/mend.10.1.8838145)
101. Raben MS 1958 Treatment of a pituitary dwarf with human growth hormone. Journal of Clinical Endocrinology and Metabolism 18 901-903. (doi:10.1210/jcem-18-8-901)
102. Rabinowitz D, Klassen GA&Zierler KL 1965 Effect of human growth hormone on muscle and adipose tissue metabolism in the forearm of man. Journal of Clinical Investigation 44 51-61. (doi:10.1172/JCI105126)
103. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD&Wondisford FE 1992 A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257 1115-1118. (doi:10.1126/science.257.5073.1115)
104. Raivio T, Avbelj M, McCabe MJ, Romero CJ, Dwyer AA, Tommiska J, Sykiotis GP, Gregory LC, Diaczok D, Tziaferi V et al. 2012 Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. Journal of Clinical Endocrinology and Metabolism 97 E694-E699. (doi:10.1210/jc.2011-2938)
105. Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J&Skakkebae NE 1995 Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. Journal ofClinical Endocrinology and Metabolism 80 1407-1415. (doi:10.1210/jcem.80.4.7536210)
106. Reichlin S 1961 Growth hormone content of pituitaries from rats with hypothalamic lesions. Endocrinology 69 225-230. (doi:10.1210/endo-69-2-225)
107. Reichlin S, Saperstein R, Jackson IM, Boyd AE III&Patel Y 1976 Hypothalamic hormones. Annual Review of Physiology 38 389-424. (doi:10.1146/annurev.ph.38.030176.002133)
108. Rivier J, Spiess J, Thorner M&Vale W 1982 Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 300 276-278. (doi:10.1038/300276a0)
109. Romshe CA, Zipf WB, Miser A, Miser J, Sotos JF & Newton WA 1984 Evaluation of growth hormone release and human growth hormone treatment in children with cranial irradiation-associated short stature. Journal of Pediatrics 104 177-181. (doi:10.1016/S0022-3476(84)80988-9)
110. Sandret L, Maison P&Chanson P 2011 Place of cabergoline in acromegaly: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 96 1327-1335. (doi:10.1210/jc.2010-2443)
111. Sassolas G 2000 Growth hormone-releasing hormone: past and present. Hormone Research 53(Suppl 3) 88-92. (doi:10.1159/000023540)
112. Scherer PE, Williams S, Fogliano M, Baldini G&Lodish HF 1995 A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological Chemistry 270 26746-26749. (doi:10.1074/jbc.270.45.26746)
113. Sheng HZ, Zhadanov AB, Mosinger B Jr, Fujii T, Bertuzzi S, Grinberg A, Lee EJ, Huang SP, Mahon KA&Westphal H 1996 Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 272 1004-1007. (doi:10.1126/science.272.5264.1004)
114. Siler TM, VandenBerg G, Yen SS, Brazeau P, Vale W&Guillemin R 1973 Inhibition of growth hormone release in humans by somatostatin. Journal of Clinical Endocrinology and Metabolism 37 632-634. (doi:10.1210/jcem-37-4-632)
115. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP et al. 1996 Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384 327-333. (doi:10.1038/384327a0)
116. Spiliotis BE, August GP, Hung W, Sonis W, Mendelson W&Bercu BB 1984 Growth hormone neurosecretory dysfunction. A treatable cause of short stature. Journal of the AmericanMedical Association 251 2223-2230. (doi:10.1001/jama.1984.03340410031028)
117. Spoudeas HA, Matthews DR, Brook CG&Hindmarsh PC 1992 The effect of changing somatostatin tone on the pituitary growth hormone and thyroid-stimulating hormone responses to their respective releasing factor stimuli. Journal of Clinical Endocrinology and Metabolism 75 453-458. (doi:10.1210/jcem.75.2.1353504)
118. Suga H, Kadoshima T, Minaguchi M, Ohgushi M, Soen M, Nakano T, Takata N, Wataya T, Muguruma K, Miyoshi H et al. 2011 Self-formation of functional adenohypophysis in three-dimensional culture. Nature 480 57-62. (doi:10.1038/nature10637)
119. Sun Y, Ahmed S&Smith RG 2003 Deletion of ghrelin impairs neither growth nor appetite. Molecular and Cellular Biology 23 7973-7981. (doi:10.1128/MCB.23.22.7973-7981.2003)
120. Takano K, Hizuka N, Shizume K, Asakawa K, Miyakawa M, Hirose N, Shibasaki T&Ling NC 1984 Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism. Journal of Clinical Endocrinology and Metabolism 58 236-241. (doi:10.1210/jcem-58-2-236)
121. Tannenbaum GS, Gurd W & Lapointe M 1998 Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone. Endocrinology 139 3871-3875. (doi:10.1210/endo.139.9.6206)
122. Tatsumi K, Miyai K, Notomi T, Kaibe K, Amino N, Mizuno Y&Kohno H 1992 Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nature Genetics 1 56-58. (doi:10.1038/ng0492-56)
123. Veldhuis JD, Metzger DL, Martha PM Jr, Mauras N, Kerrigan JR, Keenan B, Rogol AD&Pincus SM 1997 Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. Journal of Clinical Endocrinology and Metabolism 82 3414-3420. (doi:10.1210/jcem.82.10.4317)
124. Veldhuis JD, Keenan DM&Pincus SM 2008 Motivations and methods for analyzing pulsatile hormone secretion. Endocrine Reviews 29 823-864. (doi:10.1210/er.2008-0005)
125. Veldhuis JD, Roelfsema F, Keenan DM&Pincus S 2011 Gender, age, body mass index, and IGF-I individually and jointly determine distinct GH dynamics: analyses in one hundred healthy adults. Journal of Clinical Endocrinology and Metabolism 96 115-121. (doi:10.1210/jc.2010-1669)
126. Veldhuis JD, Norman C, Miles JM&Bowers CY 2012 Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men. Journal of Clinical Endocrinology and Metabolism 97 4753-4760. (doi:10.1210/jc.2012-2567)
127. Wagner C, Caplan SR&Tannenbaum GS 1998 Genesis of the ultradian rhythm of GH secretion: a new model unifying experimental observations in rats. American Journal of Physiology 275 E1046-E1054.
128. Wajnrajch MP, Gertner JM, Harbison MD, Chua SC Jr&Leibel RL 1996 Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nature Genetics 12 88-90. (doi:10.1038/ng0196-88)
129. Webb EA, AlMutair A, Kelberman D, Bacchelli C, Chanudet E, Lescai F, Andoniadou CL, Banyan A, Alsawaid A, Alrifai MT et al. 2013 ARNT2 mutation causes hypopituitarism, post-natal microcephaly, visual and renal anomalies. Brain 136 3096-3105. (doi:10.1093/brain/awt218)
130. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE & Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 86 1930-1935. (doi:10.1210/jcem.86.5.7463)
131. Wittekind DA&Kluge M 2015 Ghrelin in psychiatric disorders - a review. Psychoneuroendocrinology 52C 176-194. (doi:10.1016/j.psyneuen.2014.11.013)
132. Wu W, Cogan JD, Pfaffle RW, Dasen JS, Frisch H, O'Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS et al. 1998 Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nature Genetics 18 147-149. (doi:10.1038/ng0298-147)
133. Xie X, Zhang J, Chen D, Pan H, Wu Z, Ge D & Yang G 2015 Effects of ghrelin on postresuscitation brain injury in a rat model of cardiac arrest. Shock 43 490-496. (doi:10.1097/SHK.0000000000000337)
134. Xu JL, Xia R, Min X, Sun ZH&Liu C 2015 Ghrelin and its emerging role in tumor pathogenesis and progression. Obesity Research&Clinical Practice 9 184-185. (doi:10.1016/j.orcp.2015.01.001)
135. Yamada Y, Post SR, Wang K, Tager HS, Bell GI&Seino S 1992 Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. PNAS 89 251-255. (doi:10.1073/pnas.89.1.251)
136. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C & Hsueh AJ 2005 Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 996-999. (doi:10.1126/science.1117255)